GCC Universe · Company profile

Takeda Pharmaceutical GCC in India

Takeda Pharmaceutical is listed in GCC Universe under Pharmaceuticals, Healthcare & Life Sciences. Its recorded India locations are Bengaluru and Hyderabad.

Last researched:

Company overview

Sector
Pharmaceuticals, Healthcare & Life Sciences
Sub-sector
Pharmaceuticals
Mandate (derived)
Multi-Function / Full-Stack GCC
Parent headquarters
Tokyo, Tokyo, Japan
Parent revenue (USD)
$29,900,000,000
Parent headcount
14,726
India headcount
Not disclosed

GCC locations

  • Bengaluru
  • Hyderabad

Department mix

Global department counts, used as a proxy for the India mandate. These are not India team counts.

Engineering
2,994
Operations
2,297
Sales
1,787
Business Development
1,566
Information Technology
1,156
Finance
914
Marketing
787
Human Resources
714
Legal
548
Support
424
Data Science
356
Media And Commmunication
285
Consulting
252
Product Management
202
Administrative
178
Accounting
160
Arts And Design
94
Education
10
Entrepreneurship
2

Technology stack

  • .GIS
  • .NET
  • 3M 360 Encompass - Health Analytics Suite
  • ABAP
  • ABB Distributed Control Systems (DCS)
  • ABB Robotics
  • ABBYY FineReader Server
  • AC500 PLC
  • ADP GlobalView Payroll
  • AI
  • AMP
  • ANGEL LMS
  • AT&T
  • AVEVA Historian
  • AVEVA InTouch HMI

Public leadership

Drupendra Bahuguna

Managing Director - Zydus Takeda India

Public leadership listed in the dataset; the role is not necessarily the India GCC head.

Research overview

Takeda Pharmaceutical Company Limited is a Tokyo-headquartered, R&D-driven global biopharmaceutical leader focused on gastroenterology, rare diseases, plasma-derived therapies, immunology/inflammation, oncology, neuroscience and vaccines. FY23 revenue ~$28.2 billion with $4.8 billion R&D investment.

India launch
2025
Maturity
Scaling

The center is roughly 18 months old (launched Jan 2025) but on an aggressive scale-up trajectory (275 to 750 employees within its first year) with a stated 3-5 year roadmap to become a full digital-biopharmaceutical capability hub; still lists ~96 open India roles as of Aug 2026.

Location rationale

Bengaluru was selected for its concentration of niche talent in AI, robotics and software engineering, reinforced by Karnataka's State GCC Policy incentives; Takeda's Chief Data and Technology Officer stated that 'tapping into local talent is vital' to the center's mission.

Timeline

  1. 2025-01-15

    Takeda inaugurates its first Asian Innovation Capability Center (ICC) - its India GCC - at Bhartiya City IT Park, Bengaluru, following prior ICCs in Slovakia and Mexico.

  2. 2025-01-15

    At launch, the Bengaluru ICC employs approximately 275 specialists, with a stated target of growing to ~750 employees by end of 2025.

Real estate

Bhartiya City IT Park, Bengaluru - confirmed as the site of Takeda's ICC (India GCC) launch and current operations.

Hiring signal

Open roles
96
As of
2026-08-26
  • Data, Digital & Technology (58 open roles)
  • Insights & Analytics (22 open roles)
  • Head of Global Capabilities Center (GCC) I&A

News and developments

Takeda opens Bengaluru ICC, targets 750 employees to boost India presence

Launch of Takeda's first Asian Innovation Capability Center in Bengaluru.

2025-01-15 Business Standard ↗

Takeda expands presence in India with launch of Global Innovation Capability Centre in Bengaluru

Coverage of the ICC launch.

2025-01-15 BioSpectrum India ↗

Specialised GCC for Digital Health and R&D: Everything on Takeda's ICC in Bengaluru

Deep-dive on the center's mandate.

2025-01 eHealth (Elets) ↗

Sources

Sources and research notes

Source: Indian GCC 2026 Master Compendium, Company Master and research records. Sector, mandate and public leadership are derived fields. Missing values are shown as not disclosed. Revenue and global headcount describe the parent company, not the India centre.